Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...

Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase Manage ...

Good morning, and welcome to the PAVmed's Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I would now like to ...

Good afternoon, and welcome to NuScale's Third Quarter 2025 Earnings Results Conference Call. Today's call is being recorded. A replay of today's conference call will be available and accessible on ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Thank you for standing by. My name is Tina, and I will be your ...

An overview of the role of the navigator, its history and evolution, and the development of practice standards are discussed.

This week’s AIRmail examines the rising costs and fragmentation of sports broadcasting, insights from Rouleur Live, Chris ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

Readers’ letters on Bill Gates’ climate turnaround, the political gyrations on emissions, advice to the PM on COP31, accounting regulations and the new meme craze.

We list the best project management software, to make it simple and easy to manage projects more efficiently and effectively. With the normalization of home and hybrid work following the COVID-19 ...